The ATM overhang may pressure the stock as the company can sell shares at market prices. Monitor daily volume and any sales announcements. The company now has significant cash reserves after the private placement and this ATM, potentially reducing near-term funding risk but increasing dilution.
Price Chart
Executive Summary
Climb Bio filed a prospectus supplement for an at-the-market (ATM) offering of up to $100 million in common stock through Jefferies. The proceeds will be used for general corporate purposes, including R&D and working capital. This ATM adds potential dilution of ~9.2 million shares (16% of current float) on top of recent capital raises, creating near-term overhang.
Key Facts
- ATM offering of up to $100 million in common stock
- Jefferies LLC acting as sales agent with up to 3.0% commission
- Proceeds for general corporate purposes including R&D and working capital
- Potential dilution of approximately 9,165,902 shares at $10.91 per share
- No minimum offering amount; sales at market prices over time
- Follows April 2026 private placement that raised ~$103.4 million
Financial Impact
Up to $100 million in gross proceeds, net proceeds after commissions and expenses (estimated $400k) will vary
Risk Factors
- Immediate dilution of ~16% if the full $100 million is sold at current prices
- Continuous downward pressure on stock price due to potential share sales
- Uncertain use of proceeds and management discretion over capital allocation
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001193125-26-269510 |
| Document: 0001193125-26-269510-index-headers.html | 0001193125-26-269510 |
| Document: 0001193125-26-269510-index.html | 0001193125-26-269510 |
| Document: 0001193125-26-269510.txt | 0001193125-26-269510 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | — | awaiting T+1 | — | — |
Oct 23, 2026 3d ago | 8-K | $10.47 | awaiting T+1 | — | $8.81 (−15.85%) |
Oct 23, 2026 3d ago | Press Release | $10.34 | awaiting T+1 | — | $8.81 (−14.80%) |
Sep 22, 2026 4w ago | Institutional Cluster | $14.21 $12.52 | ▼ −11.89% | ▼ −11.17% | $8.81 (−38.00%) |
Sep 3, 2026 7w ago | 8-K | $14.59 $15.52 | ▲ +6.37% | ▲ +6.76% | $8.81 (−39.62%) |
Aug 14, 2026 10w ago | 8-K | $16.33 $17.44 | ▲ +6.80% | ▲ +7.27% | $8.81 (−46.05%) |
Aug 6, 2026 11w ago | 8-K | $14.00 $14.00 | · 0.00% | ▼ −0.61% | $8.81 (−37.07%) |
Jun 30, 2026 16w ago | 144 | $13.29 $12.90 | ▼ −2.93% | ▼ −2.80% | $8.81 (−33.71%) |
Jun 12, 2026 19w ago | 8-K | $11.49 $10.71 | ▲ +6.79% | ▲ +6.19% | $8.81 (+23.32%) |
Jun 12, 2026 19w ago | 424B5 | $11.49 $10.71 | ▲ +6.79% | ▲ +6.19% | $8.81 (+23.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers